Physician profile
Daniel J Weber
NPI 1942520762
$17,227.23
in general payments reported to CMS, 2019-2025
22 companies · $1,921 in 2025
The $1,921 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.29 · 2020: $1,709 · 2021: $5,932 · 2022: $1,183 · 2023: $3,192 · 2024: $3,268 · 2025: $1,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,922 · Food and Beverage: $3,297 · Consulting Fee: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,921.61 |
| Food and Beverage | $3,296.83 |
| Consulting Fee | $1,162.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,911.80 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Sapien 3 Ultra Resilia |
| Intuitive Surgical, INC. | $4,694.14 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $1,680.95 | 2020-2025 | Advantagerib, Ribfix Titan, Sternalock Blu System |
| W. L. Gore & Associates, INC. | $1,318.37 | 2024 | Gore Tag Conformable Thoracic Stent Graft, Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Astrazeneca Pharmaceuticals LP | $1,162.50 | 2024 | |
| Medtronic, INC. | $1,058.62 | 2021-2022 | |
| Atricure, INC. | $758.39 | 2020-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Artivion, INC. | $700.08 | 2020-2021 | |
| Abiomed | $292.64 | 2024-2025 | Impella |
| Ethicon INC. | $170.31 | 2025 | Monarch Platform |
| Boston Scientific Corporation | $101.90 | 2022-2024 | Watchman Flx |
| Davol INC. | $90.31 | 2022-2024 | Progel Applicator Spray Tips |
| Merck Sharp & Dohme LLC | $55.13 | 2025 | Verquvo |
| Kls-Martin L.P. | $48.81 | 2022-2024 | |
| Ethicon US, LLC | $42.85 | 2022-2024 | Prolene, Echelon Flex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $27.74 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Angiodynamics, INC. | $21.34 | 2020 | |
| Cvrx, INC. | $20.37 | 2024 | Barostim Neo System |
| Kci USA, INC. | $19.58 | 2023 | Activ.A.C., V.A.C. Veraflo, V.A.C. Dermatac |
| Solventum Corporation | $18.72 | 2024 | Activ.A.C. |
| Sanara Medtech INC. | $17.20 | 2023 | Celleraterx |
| Sanofi-Aventis U.S. LLC | $15.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.